Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 09 symbols : Snynf save search
Sanofi and SOBI Hit Phase III Endpoint in Severe Hemophilia A
Published: 2022-03-09 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: 0.0%
BioNTech and Regeneron Turn Attention to NSCLC in Partnership Expansion
Published: 2022-03-09 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: 0.0%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: 5.59%
H: 6.51%
C: 3.61%
partnership expansion
Lyra Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-09 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
BSX | $67.96 -0.24% 1.53% 6.2M
|
Health Technology
|
| O: -1.29%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: 0.0%
LYRA | $5.405 0.09% 0.09% 300K
|
Health Technology
|
| O: -8.93%
H: 1.79%
C: -2.63%
BIIB | $192.13 -1.55% -1.57% 1.3M
|
Health Technology
|
| O: 2.65%
H: 1.72%
C: -1.88%
financial results therapeutics report results
Efanesoctocog alfa met primary and key secondary endpoints in pivotal study in hemophilia A, demonstrating superiority to prior factor prophylaxis treatment
Published: 2022-03-09 (Crawled : 10:00) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: 0.0%
treatment
Efanesoctocog alfa met primary and key secondary endpoints in pivotal study in haemophilia A, demonstrating superiority to prior factor prophylaxis treatment
Published: 2022-03-09 (Crawled : 07:00) - prnewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 1.41%
H: 0.0%
C: 0.0%
treatment haemophilia
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.